Tc-99-exorphin C: A new peptide radiopharmaceutical for tumor imaging

---

Copy For Citation

Ertay T., ÜNAK P., Tasci C., Biber F., ZİHNİOĞLU F., Durak H.

JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, vol.265, no.3, pp.473-479, 2005 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 265 Issue: 3
• Publication Date: 2005
• Doi Number: 10.1007/s10967-005-0851-1
• Journal Name: JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.473-479
• Dokuz Eylül University Affiliated: Yes

Abstract

The aim of this study was to label exorphin C with Tc-99m and to examine its usefulness as opioid receptor binding radiopharmaceutical in Albino Wistar rats. Exorphin C, which is a peptide with 5 aminoacids, was labeled with Tc-99m using glucoheptonate (GH) as a bifunctional chelating agent. Labeling efficiency was higher than 98%. The compound was stable for at least 5 hours at room temperature. Mammary tumor bearing Albino Wistar rats were imaged using gamma-camera. Biodistribution studies were also performed. Results demonstrated that Tc-99m-glucoheptonate-exorphin C(Tc-99m-GE) analogs may be useful as a new class of receptor-binding peptides for the diagnosis and therapy of some cancer diseases related with opioid receptor-expressing tissues.